These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 35723359)

  • 1. Propensity Score-Matched Analysis to Identify Pathways Associated with Loss of Sodium Iodide Symporter in Papillary Thyroid Cancer.
    Lee F; Kuo CY; Tsai CH; Cheng SP
    Curr Issues Mol Biol; 2022 Mar; 44(4):1488-1496. PubMed ID: 35723359
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Novel Tyrosine Kinase Inhibitor Can Augment Radioactive Iodine Uptake Through Endogenous Sodium/Iodide Symporter Expression in Anaplastic Thyroid Cancer.
    Oh JM; Baek SH; Gangadaran P; Hong CM; Rajendran RL; Lee HW; Zhu L; Gopal A; Kalimuthu S; Jeong SY; Lee SW; Lee J; Ahn BC
    Thyroid; 2020 Apr; 30(4):501-518. PubMed ID: 31928162
    [No Abstract]   [Full Text] [Related]  

  • 3. Molecular mechanisms of radioactive iodine refractoriness in differentiated thyroid cancer: Impaired sodium iodide symporter (NIS) expression owing to altered signaling pathway activity and intracellular localization of NIS.
    Oh JM; Ahn BC
    Theranostics; 2021; 11(13):6251-6277. PubMed ID: 33995657
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of sodium/iodide symporter overexpression in inhibiting thyroid cancer cell invasion and stem cell maintenance by inhibiting the β-catenin/LEF-1 pathway.
    Luo NF; Li JL; Lv J; Chen FK; Li YN; Tang M; Liu PJ
    Heliyon; 2024 Mar; 10(6):e27840. PubMed ID: 38545139
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reintroducing the Sodium-Iodide Symporter to Anaplastic Thyroid Carcinoma.
    Schmohl KA; Dolp P; Schug C; Knoop K; Klutz K; Schwenk N; Bartenstein P; Nelson PJ; Ogris M; Wagner E; Spitzweg C
    Thyroid; 2017 Dec; 27(12):1534-1543. PubMed ID: 29032724
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Association Between Radioiodine Refractory in Papillary Thyroid Carcinoma, Sodium/Iodide Symporter Expression, and
    Anekpuritanang T; Uataya M; Claimon A; Laokulrath N; Pongsapich W; Pithuksurachai P
    Onco Targets Ther; 2021; 14():3959-3969. PubMed ID: 34234465
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Targeting Novel Sodium Iodide Symporter Interactors ADP-Ribosylation Factor 4 and Valosin-Containing Protein Enhances Radioiodine Uptake.
    Fletcher A; Read ML; Thornton CEM; Larner DP; Poole VL; Brookes K; Nieto HR; Alshahrani M; Thompson RJ; Lavery GG; Landa I; Fagin JA; Campbell MJ; Boelaert K; Turnell AS; Smith VE; McCabe CJ
    Cancer Res; 2020 Jan; 80(1):102-115. PubMed ID: 31672844
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Functional Radionuclide Imaging, In-Vitro Radioiodine Uptake Estimation and RT-PCR in the Evaluation of Sodium Iodide Symporter (NIS) Expression and Functionality in Breast Cancer: A Pilot Study.
    Joseph JK; Patel RB; Damle AA; Nair N; Badwe RA; Basu S
    Indian J Surg Oncol; 2013 Mar; 4(1):80-91. PubMed ID: 24426705
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sodium/iodide symporter: a key transport system in thyroid cancer cell metabolism.
    Filetti S; Bidart JM; Arturi F; Caillou B; Russo D; Schlumberger M
    Eur J Endocrinol; 1999 Nov; 141(5):443-57. PubMed ID: 10576759
    [TBL] [Abstract][Full Text] [Related]  

  • 10. TNFα-mediated activation of NF-κB downregulates sodium-iodide symporter expression in thyroid cells.
    Faria M; Domingues R; Paixão F; Bugalho MJ; Matos P; Silva AL
    PLoS One; 2020; 15(2):e0228794. PubMed ID: 32049985
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Distribution of Na+/I- symporter in thyroid cancers in an iodine-deficient population: an immunohistochemical study.
    Mishra A; Pal L; Mishra SK
    World J Surg; 2007 Sep; 31(9):1737-1742. PubMed ID: 17653791
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The importance of sodium/iodide symporter (NIS) for thyroid cancer management.
    Carvalho DP; Ferreira AC
    Arq Bras Endocrinol Metabol; 2007 Jul; 51(5):672-82. PubMed ID: 17891230
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Sodium iodide symporter in physiology and diseases -- the current state of knowledge].
    Wolny M; Syrenicz A
    Endokrynol Pol; 2007; 58(6):512-21. PubMed ID: 18205108
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sodium iodide symporter: its role in nuclear medicine.
    Chung JK
    J Nucl Med; 2002 Sep; 43(9):1188-200. PubMed ID: 12215558
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sodium iodide symporter and the radioiodine treatment of thyroid carcinoma.
    Chung JK; Youn HW; Kang JH; Lee HY; Kang KW
    Nucl Med Mol Imaging; 2010 Apr; 44(1):4-14. PubMed ID: 24899932
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Enhancement of sodium/iodide symporter expression in thyroid and breast cancer.
    Kogai T; Taki K; Brent GA
    Endocr Relat Cancer; 2006 Sep; 13(3):797-826. PubMed ID: 16954431
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Estimation of sodium/iodide symporter gene expression (NIS) in thyroid cancer by RT-PCR technique (preliminary study)].
    Tosiek M; Pomorski L; Balcerczak E; Mirowski M; Czyz W
    Endokrynol Pol; 2005; 56(1):25-9. PubMed ID: 16335670
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increasing the effectiveness of radioactive iodine therapy in the treatment of thyroid cancer using Trichostatin A, a histone deacetylase inhibitor.
    Zarnegar R; Brunaud L; Kanauchi H; Wong M; Fung M; Ginzinger D; Duh QY; Clark OH
    Surgery; 2002 Dec; 132(6):984-90; discussion 990. PubMed ID: 12490845
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Switching from MAPK-dependent to MAPK-independent repression of the sodium-iodide symporter in 2D and 3D cultured normal thyroid cells.
    Ingeson-Carlsson C; Nilsson M
    Mol Cell Endocrinol; 2013 Dec; 381(1-2):241-54. PubMed ID: 23969277
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sodium Iodide Symporter (NIS) in the Management of Patients with Thyroid Carcinoma.
    Chung JK; Kim HW; Youn H; Cheon GJ
    Nucl Med Mol Imaging; 2018 Oct; 52(5):325-326. PubMed ID: 30344779
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.